African histoplasmosis – an underdiagnosed tropical disease in Ghana
1 Dermatology Unit, Department of Internal Medicine, School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
2 Department of Obstetrics and Gynaecology, School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
3 Department of Internal Medicine, Komfo Anokye Teaching Hospital, Kumasi, Ghana.
4 Department of Pathology, Komfo Anokye Teaching Hospital, Kumasi, Ghana.
Case Study
World Journal of Advanced Research and Reviews, 2020, 07(01), 178-182
Article DOI: 10.30574/wjarr.2020.7.1.0257
Publication history:
Received on 12 July 2020; revised on 17 July 2020; accepted on 18 July 2020
Abstract:
African histoplasmosis is a mycotic infection mostly confined to Madagascar, Western and Central Africa with a few rare cases reported outside these endemic areas. Despite being in the endemic zone, few cases have been reported from Ghana. A 36 year old woman developed inexplicable left knee pain and four months later noticed nodular eruptions at the posterior aspect of her neck which subsequently spread to involve other body areas. She had associated generalized lymphadenopathy but no constitutional symptoms and screening for human immune-deficiency virus was negative. Biopsy confirmed African histoplasmosis and after fourteen months treatment with itraconazole during which she experienced periods of remission and relapse, symptoms resolved. Clinicians in African histoplasmosis endemic regions need to consider this diagnosis in patients presenting with systemic mycosis. Though treatment is generally rewarding, prolonged periods of treatment are required as well as long term follow up due to frequent relapse.
Keywords:
Systemic mycosis; Endemic; Itraconazole; Remitting; Relapsing
Full text article in PDF:
Copyright information:
Copyright © 2020 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0